Skip to main content
. Author manuscript; available in PMC: 2015 Nov 23.
Published in final edited form as: Ann Rheum Dis. 2012 Apr 4;71(9):1502–1509. doi: 10.1136/annrheumdis-2011-201089

Table 2.

Characteristics of cumulative neuropsychiatric syndromes incorporating attribution models A and B over the study period in SLE patients.

NP events (%) regardless of attribution NP events due to SLE (model A) NP events due to SLE (Model B) NP events due to non-SLE causes
Headache 657 (48.4) 0 0 657
Mood disorders 213 (15.7) 33 73 140
Seizure disorder 91 (6.7) 59 78 13
Anxiety disorder 70 (5.2) 0 0 70
Cerebrovascular disease 70 (5.2) 28 68 2
Cognitive dysfunction 61 (4.5) 12 35 26
Polyneuropathy 44 (3.2) 16 20 24
Acute confusional state 33 (2.4) 16 26 7
Mononeuropathy 27 (2.0) 14 27 0
Psychosis 23 (1.7) 10 22 1
Cranial neuropathy 24 (1.8) 20 20 4
Movement disorder 11 (0.8) 4 8 3
Myelopathy 13 (1.0) 7 12 1
Aseptic meningitis 8 (0.6) 5 5 3
Demyelinating syndrome 6 (0.4) 1 6 0
Autonomic disorder 2 (0.2) 2 2 0
Plexopathy 1 (0.1) 0 0 1
Guillain-Barre syndrome 2 (0.2) 2 2 0
Myasthenia gravis 2 (0.2) 0 2 0

Total 1358 229 406 952
% among 1358 NP events 16.9 29.9 70.1
*

The attribution of neuropsychiatric (NP) events to SLE was determined using two attribution models:

Attribution Model A: NP events which had their onset within the enrollment window and had no “exclusions” or “associations” and were not one of the NP events identified by Ainiala (12) were attributed to SLE.

Attribution Model B: NP events which had their onset within 10 years of the diagnosis of SLE and were still present within the enrollment window and had no “exclusions” and were not one of the NP events identified by Ainiala (12) were attributed to SLE.